Probe into hip replacement parts

MEDICAL device maker Stryker has launched an investigation into a potential manufacturing issue with a product made at its Cork facility following concerns from the American Food and Drug Administration (FDA).

This announcement comes a day after the FDA ordered Stryker to fix a host of problems in its manufacturing of hip replacement parts at its New Jersey plant following multiple patient complaints. The investigation concerns a product known as Trident Acetabular Cups, a replacement hip product.

The investigation follows a warning letter sent by the FDA to the Cork plant following a site investigation.